"GlaxoSmithKline is getting rich from swine flu vaccine sales. GSK, which has already sold 440m doses of its vaccine Pandemrix worldwide, said sales would hit £1bn this quarter. GSK confirmed in July that it would cost developed countries about 7 Euros (£6.30) for each dose, but it has declined to reveal production costs amid speculation it costs as little as £1 a dose to make." (Observer, 1 November) RD
The Glasgow & Edinburgh Branches Blog. Towards a better understanding of the world, in order to change it.
No comments:
Post a Comment